Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
59.97
-0.11 (-0.18%)
Jul 11, 2025, 10:41 AM - Market open

Doximity Revenue

In the fiscal year ending March 31, 2025, Doximity had annual revenue of $570.40M with 19.98% growth. Doximity had revenue of $138.29M in the quarter ending March 31, 2025, with 17.14% growth.

Revenue (ttm)
$570.40M
Revenue Growth
+19.98%
P/S Ratio
19.68
Revenue / Employee
$687,228
Employees
830
Market Cap
11.26B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Mar 31, 2025 570.40M 94.98M 19.98%
Mar 31, 2024 475.42M 56.37M 13.45%
Mar 31, 2023 419.05M 75.50M 21.98%
Mar 31, 2022 343.55M 136.65M 66.05%
Mar 31, 2021 206.90M 90.51M 77.76%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings